rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Nancy Freda Smith

Director

Company insider

Files Form 4 as: Director, Tempest Therapeutics; Director, Chuy's Holdings.

In numbers

Trades disclosed
3
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
15 May 2024
Last trade
22 Sep 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TPST Tempest TherapeuticsDirector · Biotechnology · last 22 Sep 20260 buys · 0 sells
Chuy's HoldingsDirector · last 11 Oct 20240 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
22 Sep 2026filed 2 Oct 2026TPST Tempest Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
11 Oct 2024filed 15 Oct 2024Chuy's Holdingsoption or derivativeSEC FORM 4 Code D—1,084filing
15 May 2024filed 17 May 2024Chuy's Holdingsoption or derivativeSEC FORM 4 Code A—1,084 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Matthew AngelCEO and President · CEO and President at Tempest Therapeutics, filing Form 4 there in the last year
John D. YeeDirector · Director at Tempest Therapeutics, filing Form 4 there in the last year
William Drake RicheyDirector · Director at Tempest Therapeutics, filing Form 4 there in the last year
Justin TrojanowskiCorporate Controller · Corporate Controller at Tempest Therapeutics, filing Form 4 there in the last year
Nicholas MaestasChief Financial Officer · Chief Financial Officer at Tempest Therapeutics, filing Form 4 there in the last year